Dermata Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 12,000 | $19,680 | 0.00% | 0.77% |
| UBS GROUP AG | 11/14/2024 | 4,242 | $42 | -15.87% | 0.27% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 100 | $1 | -50.00% | 0.01% |
| WARBERG ASSET MANAGEMENT LLC | 11/06/2024 | 0 | $0 | -100.00% | 0.00% |
Dermata Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of Dermata Therapeutics, Inc.. The most heavily invested institutionals were:
BOOTHBAY FUND MANAGEMENT, LLC: 12,000
UBS Group AG: 4,242
BANK OF AMERICA CORP /DE/: 100
Warberg Asset Management LLC: 0
Empery Asset Management, LP: 175,000
1.05% of Dermata Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 191,342 shares in the last 24 months. This purchase volume represents approximately $1,913 in transactions.